Rates in U.S. currency Early Bird (until Nov 30) Regular

MD/PhD: Union (IUATLD) Member $525.00 $575.00 Non-Member $575.00 $625.00

Nurses/Allied Healthcare: Union (IUATLD) Member $375.00 $425.00 Non-Member $425.00 $475.00

Students: $300.00Day Pass: $300.00

Postgraduate course (free, pre-registration required)2020 and Beyond: New Tools in the Tool Box for Diagnosis, Infection Control, and Treatment

To Register: www.bc.lung.ca/NAR

Cancellation policy: Registration minus $100.00 USD processing fee will be refunded if written notice is received by December 6, 2019. Substitution may be made at any time.

Venue: Westin Michigan Ave. Hotel, 909 N Michigan Ave, Chicago, IL, U.S.A. Tel: 312-943-7200

To make hotel reservations: https://www.marriott.com/event-reservations/reservation-link.mi?id=1564589929008&key=GRP&app=resvlink

Cutoff date: January 21, 2020

REGISTRATION IS NOW OPEN

Conference Goals

Continuing EducationThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Curry International Tuberculosis Center and the Union-North America Region. The International Tuberculosis Center is accredited by ACCME to provide continuing medical education for physicians. The activity is approved for up to 21.5 continuing education credits.

The Curry International Tuberculosis Center designates this educational activity up to 21.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Curry International Center is approved as a provider of continuing education by the California State Board of Registered Nursing, Provider CEP 12308. This educational conference is approved for up to 21.5 continuing education hours. Board requirements prevents us from offering CE credit to people who arrive more than 15 minutes after the start of the training, or leave the training early. Therefore, partial credit will not be awarded.

Certificates will be available on the Curry International Tuberculosis Center website approximately twelve weeks after the educational conference to all participants who successfully complete the training. Successful completion includes attending the entire educational conference and completing an online evaluation. To view your certificate you will need to go to the training page on the Curry International Tuberculosis Center website (www.currytbcenter.ucsf.edu/trainings), log in and click on “training history.”

All CME recipients will be contacted 4 months after the course to assist with long-term evaluation activities.

At the end of this activity participants will be able to:

• describe the efforts to achieve TB elimination and practical issues in the treatment and management of latent TB infection

• facilitate compassionate conversations related to harm reduction and mitigating stigma when caring for TB patients from vulnerable communities

• explain the role of neoliberalism, universal healthcare coverage, and human rights issues related to TB care

• discuss the results of epidemiologic studies of new TB diagnostics and progression to TB disease

The Union-North America RegionExecutive CommitteeRobert Horsburgh, MD, Boston University School of Public Health, Boston, MA, USA

Lisa V. Adams, MD, Vice-President/Program Chair, Geisel School of Medicine at

Dartmouth, Hanover, NH, USA

Sarah Brode, MD, Secretary/Treasurer, Westpark Health Care, Toronto, ON, Canada

Kevin Schwartzman, MD, MPH, President–Elect, McGill University, Montreal, QC, Canada

Victoria Cook, MD, Immediate Past President, BC Centre for Disease Control,

Vancouver, BC, Canada James Johnston, MD, MPH, Immediate Past Vice-President, BC Centre for Disease

Control, Vancouver, BC, Canada

Menn Biagtan, MD, MPH, Secretariat, British Columbia Lung Association,

Vancouver, BC, Canada

Christopher Lam, Ex-officio, British Columbia Lung Association, Vancouver, BC, Canada

CME Planning CommitteeLisa V. Adams, MD, Program Chair, Geisel School of Medicine at Dartmouth,

Hanover, NH, USA

Carolyn Bargman, RN, Denver Public Health, Denver, CO, USA

Sarah Brode, MD, Westpark Health Care, Toronto, ON, Canada

Jonathon Campbell, PhD, McGill University, Montreal, QC, Canada

Victoria Cook, MD, BC Centre for Disease Control, Vancouver, BC, Canada

Eric Commiesie, MD, Ministry of Health, Paramaribo, Suriname

Cleophas Auvergne, MD, MPA, Organization of Eastern Caribbean States, Morne

Fortune, Castries, Saint Lucia

Robert Horsburgh, MD, Boston University School of Public Health, Boston, MA, USA

Shaila Jiwa, RN, BScN, MScPPH, BC Centre for Disease Control and Prevention,

Vancouver, BC, Canada

Alfred Lardizabal, MD, NJMS Global Tuberculosis Institute at Rutgers, Newark, NJ, USA

Joan Mangan, PhD, MPH, US Centers for Disease Control and Prevention, Atlanta, GA, USA

Sapna Morris, MD, US Centers for Disease Control and Prevention, Atlanta, GA, USA

Kelly Musoke, MPH, Curry International Tuberculosis Center, Oakland, CA, USA

Edward Nardell, MD, Harvard Medical School, Boston, MA, USA

Elizabeth Rea, MD, Toronto Public Health, Toronto, ON, Canada

Randall Reves, MD, MSc, Denver Public Health, Denver, CO, USA

Ann Raftery, RN, PHN, Curry International Tuberculosis Center, Oakland, CA, USA

Max Salfinger, MD, University of South Florida, College of Public Health, Tampa, FL, USA

Dean Schraufnagel, MD, University of Illinois at Chicago, Chicago, IL, USA

Elizabeth Talbot, MD, Geisel School of Medicine at Dartmouth, Hanover, NH, USA

Abstract CommitteeSarah Brode, MD, (Chair), Westpark Health Care, Toronto, ON, Canada

Shama Ahuja, PhD, MPH, New York City Department of Health and Mental Hygiene,

New York, NY, USA

Lisa Armitige, MD, PhD, Heartland National TB Center, San Antonio, TX, USA

Carolyn Bargman, RN, Denver Public Health, Denver, CO, USA

Rajita Bhavaraju, PhD, MPH, NJMS Global Tuberculosis Institute at Rutgers, Newark,

NJ, USA

E. Jane Carter, MD, Brown University, Providence, RI, USA

Affixed by stunning Lake Michigan and decorated with inspiring architecture, Chicago is more than just a big city. Besides its striking downtown area, which includes some of the tallest buildings in the world, Chicago has a distinctive shoreline, hundreds of vibrant parks and 77 unique neighborhoods. The distinctive mix of incredible attractions and cultural allure make Chicago one of the friendliest, most livable cities in America.

In Chicago you will find incredible shopping on the Magnificent Mile, a Michelin-rated dining scene and exciting nightlife. The city also boasts more than 60 museums, five regional Tony-Award winning theaters and, no matter the season, a sport team to cheer victory. Millennium Park, deep dish pizza and Wrigley Field are all exciting enough reasons to visit Chicago, but the city’s most endearing quality is its people. Chicago’s neighborhoods represent more than 100 countries and it is through this diversity, mix of global attractions and local charm that make Chicago one impressive city.

The Union-North America Region

2020TB CONFERENCEFEB 27-29, 2020

Westin Michigan Avenue Hotel

Chicago, IL, USA

Terence Chorba, MD, US Centers for Disease Control and Prevention, Atlanta, GA, USA

Victoria Cook, MD, BC Centre for Disease Control, Vancouver, BC, Canada

Ryan Cooper, MD, University of Alberta, Edmonton, AB, Canada

Charlie M. Crane, MD, MPH, Martinez, CA, USA

Kevin Elwood, MD, BC Centre for Disease Control, Vancouver, BC, Canada

Robert Horsburgh, MD, Boston University School of Public Health, Boston, MA, USA

Ian Kitai, MD, Hospital for Sick Children, Toronto, ON, Canada

Joan Mangan, PhD, MPH, US Centers for Disease Control and Prevention, Atlanta, GA, USA

E. Ann Misch, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI, USASapna Morris, MD, US Centers for Disease Control and Prevention, Atlanta, GA, USA

Sonal S. Munsiff, MD, University of Rochester Medical Center, Rochester, NY, USA

Eyal Oren, PhD, MS, San Diego State University, San Diego, CA, USA

Ann Raftery, RN, PHN, Curry International Tuberculosis Center, Oakland, CA, USA

Max Salfinger, MD, University of South Florida, College of Public Health, Tampa, FL, USA

Kevin Schwartzman, MD, MPH, McGill University, Montreal, QC, Canada

Elizabeth Talbot, MD, Geisel School of Medicine at Dartmouth, Hanover, NH, USA

Shu-Hua Wang, MD, MPH&TM, Ohio State Wexner Medical Center, Columbus, OH, USA

Rate: $152.00 USD + taxes/night

morning session - 8:30am - 12:00pm

SATURDAY FEB 29, 2020

Welcome Remarks: Dr. Lisa V. Adams and Dr. Bob Horsburgh

Patient Perspective

The George Comstock Lecture The Rocky Road to the Elimination of TBDr. Guy Marks, The Union, Paris, France

Stop TB Meeting: Elements of Success: Funding, Prevention, and Effective CommunicationChairs: Drs. Elizabeth Rea, Randall Reves, Cynthia Tschampl

Advocates Perspective on Funding Commitments and Accountability for TB Elimination: Progress since the UN High Level Meeting on TB, GFATMMr. David Bryden, RESULTS Washington, DC, USA

Short and Ultra-Short Course LTBI – Implications for the Cascade of Care in Middle- and Low-Income Countries Dr. Dick Menzies, McGill University, Montreal, QC, Canada

Estimating Local LTBI Prevalence by Country of Birth in the USDr. Jeff Collins, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA

Engaging Communities in TB Elimination through Effective CommunicationsMs. Leeanna Allen, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA

Oral Abstract Presentation #1

Stop TB Canada and Stop TB USA Meetings

Poster Session #1

Pre-registration required2020 and Beyond: New Tools in the TB Toolbox for Diagnosis, Infection Control, and TreatmentChairs: Dr. Max Salfinger and Ms. Karen Simpson

Welcome and OverviewDr. Max Salfinger and Dr. Neela Goswami

Exciting Developments - Towards Non-Sputum Based Diagnosis of TuberculosisDr. Niaz Banaei, MD, Stanford University School of Medicine, Palo Alto, CA, USA

Who’s Afraid of TB NAAT as a Rule-Out Test? Insider Tips for Safe & Effective Implementation at Your HospitalDr. J. Lucian Davis, Yale School of Public Health, New Haven, CT, USA

U.S. TB Guidelines for Drug-Resistant TB: A Critical Look at the DataDr. Barbara Seaworth, Heartland National Tuberculosis Center, San Antonio, TX, USA

Practical Experience with a 6-Month All Oral MDR-TB Regimen Dr. Francesca Conradie, University of Witwatersrand, Johannesburg, Johannesburg, SA

Panel Discussion and Q&A: Current Approaches to TB in Evolving Times

Lisa V. Adams, MD2020 Program ChairThe Union-North America Region

Plan to join us in Chicago for the END TB: 24th Annual Conference of The Union-North America Region!

Our expert planning committee has brought together an exciting lineup of speakers to discuss the current critical issues in tuberculosis care and prevention. You’ll learn about efforts to achieve TB elimination, practical issues in LTBI treatment, results of the latest TB Epidemiologic Studies Consortium findings on pediatric and adult LTBI diagnosis. In a new format, you will also hear two experts debate the issue of mass treatment for LTBI – are we undertreating or overtreating? A session on compassionate conversations will be useful to even the most seasoned providers as we discuss harm reduction and mitigating stigma when caring for TB patients from vulnerable communities. A highlight of this year’s conference will be a symposium devoted to special challenges of addressing TB in the Caribbean region. Be sure to arrive in time for our free, pre-conference postgraduate course to learn about the latest developments in TB diagnosis, drug-resistant TB treatment, and infection control practices. We are also pleased to include keynote addresses from Dr. Guy Marks, the incoming President of The Union, from Dr. Ariel Pablos-Mendez on the role of universal health coverage in TB care, and from Dr. Salmaan Keshavjee speaking on neoliberalism, global health and other human rights issues in TB care. We hope you will join us along with a diverse group of TB advocates, survivors, scientists, clinicians, and program managers to network, discuss, and debate the latest issues in TB care and prevention.

morning session - 8:00am - 12:00pm

THURSDAY FEB 27, 2020

postgraduate course - 1:00pm - 6:00pm

WEDNESDAY FEB 26, 2020Nursing Sponsored Session: Compassionate ConversationsChairs: Dr. Joan Mangan, Ms. Carolyn Bargman, Ms. Ann Raftery, and Ms. Shaila JiwaFrom Provider to Patient and Back AgainMs. Tenzin Yangzom, A TB SurvivorCompassionate Care: Lessons Learned from PatientsMs. Cheryl D. Kane, Boston Health Care for the Homeless Program, Boston, MA, USABuilding a Foundation of Respect and Mitigating StigmaDr. Vincent Waite, Greater Lawrence Family Health Center, Lawrence, MA, USAHarm Reduction: Concepts, Compassion, and Care Delivery Dr. Elizabeth Salisbury-Afshar, Center for Addiction Research and Effective Solutions (CARES), Chicago, IL, USAOral Abstract Presentation #2Panel DiscussionAwards Ceremony

afternoon session - 2:00pm - 6:00pm

afternoon session - 1:15pm - 4:00pm

TB Elimination: Macro PerspectiveChairs: Drs. Robert Horsburgh and Jonathon CampbellScreening Immigrants to Canada for LTBI: A Provincial PerspectiveDr. James Johnston, BC Centre for Disease Control, Vancouver, BC, CanadaLatent Tuberculosis Infection Screening and Treatment of Immigrants to USA from Vietnam Dr. Payam Nahid, University of California at San Francisco, San Francisco, CA, USAPrioritization of Populations for Latent Tuberculosis Infection Testing and Treatment: A Meta-AnalysisDr. Jonathon Campbell, McGill University, Montreal, QC, CanadaStrengthening Latent Tuberculosis Infection Diagnosis and Treatment for Household Contacts: Results and Reflections from the ACT4 Randomized Controlled TrialDr. Olivia Oxlade, McGill University, Montreal, QC, CanadaOral Abstract Presentation #6

Challenging TB Cases – Joint Medical, Nursing and Public HealthChairs: Drs. Victoria Cook, Sapna Morris, Alfred Lardizabal, and Elizabeth TalbotTB in the Caribbean RegionChairs: Drs. Cleophas D’Auvergne and Eric CommiesieTB in the Organization of Eastern Caribbean States Dr. Cleophas D’Auvergne, Organization of Eastern Caribbean States, Morne Fortune, Castries, Saint LuciaTB/HIV Co-Infected Continuum of Care: Identifying Factors for Improvement in SurinameDr. Deborah Stijnberg, Paramaribo, SurinameMDR-TB Treatment Outcomes over the Past 10 Years in Port-au-Prince, HaitiDr. Stalz Vilbrun, GHESKIO, Port-au-Prince, HaitiOpportunities to Tackle TB in the Wake of Natural Disasters, Haiti, 2010-2016Dr. Macarthur Charles, US Centers for Disease Control and Prevention, Atlanta, GA, USAOral Abstract Presentation #3Industry-Sponsored Satellite Symposium #1

afternoon session - 1:00pm - 5:40pmPoster Session #2Beyond TB Lecture The Global Movement for Universal Health CoverageDr. Ariel Pablos-Mendez, CUMC/Presbyterian Hospital and Vanderbilt Clinic, New York, NY, USATesting and Treating Latent Tuberculosis InfectionChairs: Drs. Dean Schraufnagel and Ed NardellImplementation of 3HP and 4R by SAT Dr. Michelle Haas, Denver Public Health, Denver, CO, USA

morning session - 8:00am - 12:00pm

FRIDAY FEB 28, 2020

Taking the Leap: TB Active-Case Finding & Micro-Elimination ProjectsChairs: Dr. Sapna Bamrah Morris and Ms. Carolyn BargmanEliminating Tuberculosis One Neighborhood at a Time: Smith County, TexasDr. Peter Cegielski, Atlanta, GA, USAEliminating TB in Nunavik Dr. Marie Rochette, Nunavik Regional Board of Health and Social Services, Kuujjuaq, QC, CanadaZero TB Cities Dr. Salmaan Keshavjee, Harvard Medical School, Boston, MA, USATB Care and Prevention in the Republic of Marshall Islands: TB Free Ebeye and Majuro Dr. Richard Brostrom, U.S. Centers for Disease Control and Prevention/ Hawaii Department of Health, Honolulu, HI, USAOral Abstract Presentation #5TB and Human Rights: Neoliberalism, Global Health and Other Human Rights Issues in TB Care Dr. Salmaan Keshavjee, Harvard Medical School, Boston, MA, USAIndustry-Sponsored Satellite Symposium #2

2675 Oak Street, Vancouver, BC, CANADA V6H 2K2

TBESC Study of Pediatric LTBI Diagnosis and Treatment Dr. Amina Ahmed, Levine Children’s Hospital, Charlotte, NC, USATBESC Study of Diagnostics and Progression to TB diseaseDr. Jennifer Flood, California Department of Public Health, Richmond, CA, USAIs Broader Treatment of Latent Tuberculosis an Important Global Elimination Strategy?Pro: Latent Tuberculosis is undertreatedDr. Dean Schraufnagel, University of Illinois, Chicago, IL, USACon: Latent Tuberculosis is being overtreatedDr. Marcel Behr, McGill University, Montreal. QC, CanadaOral Abstract Presentation #4